Cardiomyopathy, hypertrophic
Clinical trials for Cardiomyopathy, hypertrophic explained in plain language.
Never miss a new study
Get alerted when new Cardiomyopathy, hypertrophic trials appear
Sign up with your email to follow new studies for Cardiomyopathy, hypertrophic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug trial halted early: MYK-224 studied for thick heart muscle
Disease control Stopped earlyThis study tested an experimental drug called MYK-224 in 18 adults with a type of heart disease that makes the heart muscle too thick and blocks blood flow. The goal was to see if the drug is safe and helps reduce symptoms. The trial was stopped early, so results are limited.
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart drug mavacamten tested in Non-Obstructive HCM trial
Symptom relief Stopped earlyThis Phase 3 study tested the drug mavacamten in 580 adults with symptomatic non-obstructive hypertrophic cardiomyopathy, a heart muscle condition that makes it harder for the heart to pump blood. Participants received either mavacamten or a placebo. The study measured changes in…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC